Home

Mesothelioma

• About Mesothelioma
• Mesothelioma Cause
• Mesothelioma Symptoms
• Mesothelioma Diagnosis
• Mesothelioma Stages

Mesothelioma Treatment

• Treatment Options
• Mesothelioma Surgery
• Mesothelioma Chemotherapy
• Mesothelioma Radiation
• New Approaches
• Palliative Care

Mesothelioma Specialists

• Choosing Your Doctor
• Your Health Care Team
• Cancer Centers

Clinical Trials

• Trial Basics
• Eligibility
• Current Trials

Managing Your Care

• Your Personal Records
• Your Medications
• Your Expenses

Veterans Resources

• Asbestos Disease
• Mesothelioma Detection
• Asbestos Exposure
• Veteran Service Officers

NEWS ABOUT PHARMACEUTICALS IN MESOTHELIOMA TREATMENT

1. Gene Screening Proves Effective in Screening for Mesothelioma Survival
2. Ohio University Finds Bond between Asbestos, Human Cell Tissue - Could Lead to Understanding of Mesothelioma Pathogenesis
3. New Drug Regimen Aimed at Reducing Chemotherapy-Induced Nausea
4. Ranpirnase and Doxorubicin Form Effective Second Line Treatment for Malignant Mesothelioma
5. Gene Expression Ratio Test Can Predict Survival in Mesothelioma Cases
6. Personalized Treatment Prolongs Survival For Advanced Cancer Patients
7. BWH Researchers Identify Mutated Genes Unique to Mesothelioma Tumors - Brigham and Women's Hospital
8. Cancer Diagnosis From a Single Drop of Blood?
9. National mesothelioma virtual bank
10. Another Study Links Nanotubes To Mesothelioma
11. Retrofitted Antibodies Shrink Cancer Tumors and May Lead to HIV Vaccine
12. FDA Tells Manufacturers to Stop Marketing Bogus Cancer Cures
13. Morphotek Commences Phase II Study of MORAb-009 for Patients with MPM
14. Research Shows Altered Immune Cells Target Mesothelin
15. UK researchers predict rates of lung cancer will drop 20% over the next 20 years
16. Breakthrough Could Lead to New Cancer Therapies
17. Gene Fusions May Be Unique Identifier for Cancer
18. Study Examines Interactions Between Asbestos Fibers and Cells
19. Liver Tumors Treated with Chemotherapy Beads
20. Mesothelioma Researcher Receives Two Grants
21. The War on Mesothelioma: Researchers Announce Promising Results of Mesothelin-Based Immunotherapy
22. Synthetic Material Attaches to Cells to Assist in Cancer Research
23. Blood Vessel Growth Slowed with Common Chemotherapy Drugs, Slow Spread of Cancer
24. FDA Recommends Additional Clinical Trial for Onconase
25. ZenBio Awarded Phase II SBIR Grant for Cell Development
26. Researchers gain new insight into DNA replication
27. Study bolsters argument for treating cancer-related fatigue with exercise
28. Study finds new chemotherapies to be ineffective in fighting asbestos-related cancer
29. Researchers report promising gene that causes cancer cells to self destruct
30. EPA awards $2.1 million asbestos research grant
31. Cancer research may exclude older patients
32. Vitamin supplements may not help prevent cancer
33. New treatments under development for asbestos-related cancer
34. Cancer treatment errors happen more than commonly known
35. Scientists develop nanotube technology to fight cancer cells
36. Study Shows Brief Inhibition of Cancer Cells is Effective
37. Rosetta Genomics offers MicroRNA-based mesothelioma diagnostic test
38. Vitamin trials for cancer prevention offer disappointing results
39. Supressing tumors in young patients may increase cancer risk in later years
40. Mistakes in Treatment Prompt Thorough Review in Southern Australia Hospitals
41. Researchers Discover Enzyme That Signals Breast Cancer Metastasis
42. Woman Campaigns for UK Chemoembolisation Trials After Successful Treatment
43. Clinical trials struggling to attract participants
44. Study finds chemotherapy may be harmful For patients with advanced cancer
45. New cancer studies call anti-angiogenesis process into question
46. Scientists explore ways to use genes to fight cancer
47. Researchers find molecule that causes malignant cells to self-destruct
48. Research sheds light on lung cancer for non-smokers
49. Doctors look toward screening for lung cancer
50. Nanomaterial Screening helps determine which particles are toxic
51. Experts: Current pain treatment not sufficient for cancer patients
52. Massage could be beneficial for reducing cancer pain
53. New findings about chemotherapy at the molecular level
54. Transdermal patch developed for severe cancer pain
55. Too much Vitamin C may interfere with chemotherapy
56. New clues on causes of thoracic cancer
57. Telomerase gene sequence uncovered
58. Pleurodesis in the treatment and care of mesothelioma patients
59. Epigenetic drugs for cancer treatment
60. Study shows Alimta effective for maintenance therapy
61. Scientists announce advance in immunotherapy
62. Minimally invasive RFA treatment could be used for several cancer types
63. Novel strategy for cancer treatment uses patient's own blood
64. Attacking cancer stem cells a way to treat cancer
65. Predicting cancer-fighting abilities by computer
66. Anti-inflammatory drugs investigated for chemoprevention
67. Modified chemotherapy agent improves PET scan functioning
68. Government budget cuts deter progress in fight against cancer
69. Navelbine and cisplatin/pemetrexed in treatment of pleural mesothelioma
70. Tumor Generator Could Enhance Cancer Drug Development
71. Belgian doctors hit personalized cancer treatment milestone
72. New biomarkers for cancer developed
73. New cancer medicines track records fail to live up to hype
74. New research initiative to map genetic mutations behind cancer
75. Study suggests antioxidant supplements can have negative effects for cancer treatment patients.
76. Personalized medicine holds promise
77. Arenegyr Receives Orphan Drug Designation for Mesothelioma
78. Onconase Phase IIIb Trial Posts Mixed Results
79. Study finds inaccuracies in some cancer treatment research.
80. Piroxicam and Cisplatin Show Promise Against Mesothelioma CellsCarbon nanotubes may be as deadly as asbestos
81. New Study Tells Researchers How Cancer Spreads
82. Researchers uncover reasons for patients' adverse reactions to Cetuximab.
83. Study: Chemotherapy may not have any positive results on mesothelioma sufferers
84. Synthetic Molecules May Help Battle Cancer
85. Scientists Take a New Look at the Benefits of Fasting when Undergoing Chemotherapy
86. Exercise Shown to Fend Off Fatigue Caused by Cancer
87. Nanoparticles Could Deliver Cancer Drugs
88. Meta-analysis of cancer clinical trials finds 41 percent are superior to existing treatments
89. Vinflunine Shows Promise in Treating Malignant Pleural Mesothelioma
90. Synthetic Molecules Could Offer A Lower Cost Cancer Treatment Alternative
91. "Bacteria Therapy" Shows Promise in Initial Tests
92. New UCLA Machine May Kill Cancer Cells
93. Study raises doubts about some DNA-based drugs
94. Disease-Causing Bugs May Help Treat Cancer
95. New Cancer Vaccine Approved for Limited Use in Russia
96. New Therapy Targets Hepatitis C
97. Innovative New Cancer Treatment Idea Earns $1 Million Prize
98. Higher Doses of Chemotherapy Make No Difference in Small Cell Lung Cancer
99. Nanoparticles Help Advance Anticancer siRNA Therapy
100. Research at MIT Shows microRNA's Protective Role
101. Patients See Benefit From Self Reporting Symptoms Online
102. Cancer drugs from genetically modified chicken eggs
103. Researchers attempting to figure out how cancer grows
104. Antifolates - Chemotherapy drugs
105. Dopamine for cancer treatment
106. Concerns about anemia medications for cancer patients
107. Researchers Developing New Ways of Detecting Cancer
108. Recentin Study Ends
109. Phase II Study of Sutent ® Results Out
110. Terminally Ill Cancer Patients Given Hope in UK
111. New Finding on Correlation Between Angiogenesis, Breast Cancer and Inflammation
112. PET Found to be effective in the Evaluation of Cancer Treatment
113. One-tird of cancer patients experience chronic fatigue after treatment
114. New Drug Cocktails Hold Promise for Cancer, HIV Treatments.
115. New DNA Discovery Changes the Way Doctors Look at Cancer.
116. Inraperitoneal Hyperthermic Chemotherapy for Those Suffering With Abdominal Cancer
117. Mouse Model For Mesothelioma Reproduces Human Disease
118. Researchers Use Transcriptome Analysis by 454 Sequencing to Identify Tumor Specific Mutations Linked to Malignant Pleural Mesothelioma
119. Pre-Clinical Data Show Intracellular Pathways Affected by Onconase
120. Remembering a researcher’s legacy on asbestos research
121. PET proves effective in evaluating cancer treatment
122. Trial on experimental antifolate PDX (Pralatrexate)
123. American College of Physicians releases guidelines for end-of-life care
124. Web-based system helps doctors track outpatients’ chemotherapy toxicity
125. NICE Gives Final Approval for Alimta
126. Par Pharmaceuticals licenses Onconase
127. Thalidomide and Alimta to be Combined in New Clinical Trial
128. Alfacell Updates Status Of ONCONASE(R) Phase III Clinical Program
129. ONCONASE(R) has Potential as Chemopreventive Agent in Mesothelioma
130. Boysenberries might impede mesothelioma
131. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
132. New Mesothelioma Research Center to Open in Sydney
133. Virotherapy to Treat Mesothelioma
134. MIT researchers' "nanocell" delivers a toxic double whammy to tumors
135. FDA Approves the MESOMARK® Assay for the Management of Mesothelioma Patients
136. NYU School of Medicine Verifies Mesothelioma Diagnostic Test
137. Researchers Identify Intracellular Pathway of Alfacell's Onconase
138. New Study
     

     Heralds Shortened Timeline for Anticancer Drug Development

139. Talcum Powder Stunts Tumor Growth
140. Soluble mesothelin in effusions a strong indicator of mesothelioma
141. Diagnostic Tools For Lung And Mesothelioma Cancers To Be Developed
142. New Technology For Cancer Screening Listens For The Signs Of Cancer
143. Onconase(®) is in its final phase 3 trial for treatment of patients with unresectable malignant mesothelioma
144. Data Affirm Benefit of ALIMTA(®) for Patients With Malignant Pleural Mesothelioma
145. New diagnostic tool for mesothelioma to be developed: test will extract microRNAs from a simple blood draw
146. The Barbara Ann Karmanos Cancer Institute announces significant scientific findings related to Malignant Mesothelioma
147. Mild Hyperthermia Enhances Antitumor Effects of Ranpirnase
148. Study shows Mesomark effective for monitoring Mesothelioma
149. FDA Grants Orphan Drug status to Onconase for Mesothelioma
150. Alfacell Corporation Files for U.S. Orphan Drug Designation for Onconase
151. Additional Data From a Phase I Trial of XL647 in Patients With Advanced Solid Tumors
152. New study on the safety, tolerability, pharmacokinetics and preliminary efficacy of INNO-305
153. More evidence that patients treated with Onconase have greater median survival times than patients treated with doxorubicin alone
154. Zolinza becomes first approved HDAC inhibitor
155. Alimta Researchers Recognized As Heroes Of Chemistry
156. Progress on Clinical Development Program for ONCONASE(R) in Malignant Mesothelioma
157. FDA tells Eli Lilly that their Alimta brochure is misleading
158. News about onocology product candidate SS1P (renamed CAT-5001)
159. New Research Shows Unique Promise of Onconase in the Prevention and Treatment of Mesothelioma
160. CuraGen and TopoTarget Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for Mesothelioma
161. Alfacell Provides Update on ONCONASE Phase IIIb Confirmatory Registration Trial; Releases First Interim Analysis Data
162. Alfacell Achieves Full Patient Enrollment Milestone for the Onconase Phase IIIb Registration Study in Unresectable Malignant Mesothelioma
163. Scientist Reveals His Hopes for Better Tumour Treatment
164. Alfacell Drug Trial Ahead of Schedule
165. Alfacell Forms New Thoracic Cancer Advisory Board
166. Update on Onconase Clinical Program
167. Promising Research in Early Detection of Mesothelioma
168. Morphotek Announces IND Submission for MORAb-009, a Monoclonal Antibody for the Treatment of Mesothelin-Expressing Cancers
169. INNOVIVE Pharmaceuticals Licenses WT1 Peptide Cancer Immunotherapeutic from Memorial Sloan-Kettering Cancer Center
170. Gene Drug Gives Mesothelioma Patient Second Chance
171. Novel therapies for pleural mesothelioma
172. Thoracic Cancer Patients Find New Reasons for Hope with Alimta(®)

MesotheliomaWeb News Stories

Read excerpts from medical publications

Contact Us

**For a FREE information packet including treatments, clinical trials, and specialists, please complete the form above or call a Mesothelioma Web coordinator at 1-877-367-6376.

News

• Mesothelioma News
• International News
• Pharmaceutical News
• Environmental News
• Medical Journal Articles

Resources

• Leading Cancer Links
• Financial Assistance, Compensation, and Legal Rights
• About Us
• Privacy Policy
• Disclaimer and Sponsorship Information

This site complies with the HONcode standard for trustworthy health information: verify here

If you would like to receive a FREE information packet or have questions about mesothelioma, call us at:

Toll-Free 1-877-367-6376